why choose us

First received: May 17, 2024

Clinical Trial: Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hepatic Impairment

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Multi-center, Open-label Study to Assess the Pharmacokinetics and Safety of BMS-986278 in Healthy Participants and Those With Mild, Moderate and Severe Hepatic Impairment

Brief Summary: The purpose of this study is to assess the drug levels and safety of BMS-986278 in participants with mild, moderate, and severe Hepatic Impairment (HI), and in matched healthy control participants with normal hepatic function.

Read more